Bioline Rx reported $28.52M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Arca Biopharma USD 343.86M 11.31M Dec/2025
Bio Path USD 663K 17K Sep/2025
Bioline Rx USD 28.52M 3.34M Sep/2025
Capricor Therapeutics USD 322.94M 221.99M Dec/2025